Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
|Active Ingredient:||Sonidegib phosphate 280.8mg equivalent to sonidegib 200mg|
|New Zealand Sponsor:||CARSL Consulting|
|Manufacturer:||Patheon Inc, Mississauga, Canada|
Dated this 29th day of November 2019.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).